Japanese retail investors have fully taken up a pioneering $223m bond to fund vaccination programmes in the developing world, paving the way for further such offers in other markets in the future.
Individuals paying as little as $1,270 each bought all of a small second issue from the International Finance Facility for Immunisation (IFFim), which was denominated in South African rand and sold in Tokyo.




